Nanjing reginecore Biotechnology Co, Ltd

Nanjing reginecore Biotechnology Co, Ltd is invested and established by Youngy Group, relying on the nano-antibody technology established by the chief scientist Professor Xie Wei of Southeast University, and cooperating with domestic and foreign experts from Harvard Medical School / Massachusetts General Hospital and University of Toronto, Canada, to focus on in-depth research and development of new generation of high-tech products based on nano antibody.
 
The R & D pipeline includes antibodies for diagnosis and treatment of tumors, antibodies for diagnosis and treatment of autoimmune diseases and neuroscience, and antibodies and technologies for brain science research and diagnosis and treatment of brain diseases. Among them, cell therapy pipeline based on nano antibody technology includes specific focus, specific car-t, universal cat-t, NK-T and so on.